RTTNews | Oct 13, 2020 03:20AM EDT

03:20 Tuesday, October 13, 2020 (RTTNews.com) - Nestle SA (NSRGY.PK, NSTR.L) said, in an update on results of tender offer for Aimmune Therapeutics (AIMT), that about 43.44 million Aimmune shares were validly tendered. It represented about 84% of the outstanding shares of Aimmune.

The minimum tender condition to the consummation of the offer has been satisfied, Nestle said.

In late-August, Nestl offered to buy Aimmune Therapeutics for $34.50 per share. The offer expired on October 9, 2020.

Read the original article on RTTNews ( https://www.rttnews.com/3135662/nestle-says-about-84-aimmune-shares-tendered.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved